Workflow
资源共享协同发展
icon
Search documents
华兰疫苗:公司部分疫苗产品在临床应用上与控股股东相关免疫制品具备互补性
Mei Ri Jing Ji Xin Wen· 2026-02-02 01:09
Core Viewpoint - The company, Hualan Vaccine, emphasizes its collaborative development with its controlling shareholder, Hualan Biological, focusing on shared resources and complementary product offerings in the vaccine sector [1] Group 1: Collaboration and Synergy - The company and Hualan Biological have established a solid foundation for collaboration in areas such as bioproduct research and development management, production quality system construction, supply chain management, and compliance experience [1] - Both entities are committed to the construction and management of the "Hualan" brand, which has been recognized as a famous trademark in China, indicating strong market recognition and brand reputation [1] Group 2: Product Complementarity - Certain vaccine products from the company have complementary applications with Hualan Biological's related immunological products, such as rabies vaccine and tetanus vaccine, which can be used in conjunction with corresponding human immunoglobulin to enhance both active and passive immunity [1]